Zhifen Wu

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Heterogeneity at the invasion front of triple negative breast cancer cells”.

Heterogeneity at the invasion front of triple negative breast cancer cells

Scientific Reports(2020)10.1038/s41598-020-62516-8

N/A

0DataRank · unranked

29 citations

Peter Ulintz, Sara Cáceres, Xu Cheng, Liwei Bao, Zhifen Wu +3 more

Insights into the modular design of kinase inhibitors and application to Abl and Axl

RSC Medicinal Chemistry(2021)10.1039/d1md00296a

N/A

0DataRank · unranked

4 citations

Lluís López-Barcons, Nathalie M. Vandecan, Zhifen Wu, Taylor K. Johnson, Eric J. Lachacz +3 more

RhoC Modulates Cell Junctions and Type I Interferon Response in Aggressive Breast Cancers

Frontiers in Oncology(2021)10.3389/fonc.2021.712041

N/A

0DataRank · unranked

4 citations

Peter Ulintz, Laura Goo, Joel A. Yates, Andrew C. Little, Liwei Bao +3 more

Blood–Brain Barrier Remodeling in an Organ‐on‐a‐Chip Device Showing Dkk1 to be a Regulator of Early Metastasis

Advanced NanoBiomed Research(2023)10.1002/anbr.202200036

N/A

0DataRank · unranked

13 citations

Benjamin A. Yang, Nathan Merrill, Joel A. Yates, Megan Altemus, Liam Russell +10 more

Data from p38γ Promotes Breast Cancer Cell Motility and Metastasis through Regulation of RhoC GTPase, Cytoskeletal Architecture, and a Novel Leading Edge Behavior

(2023)10.1158/0008-5472.c.6502946.v1

N/A

0DataRank · unranked

0 citations

Harish Iyer, Silvia Escudero, Liwei Bao, Zhifen Wu, Alejandra C. Ventura +5 more